About
Technology
Issues
FAQ
Links
Official Page
Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.